BENITEC BIOPHARMA INC.

NASDAQ:BNTC
Annual Meeting

of Shareholders

MEETING DATE

12/03/2026
DEF 14A FILED
10/20/2026
PUBLISHED
10/20/2026 8:25 pm
TIME TO PUBLISH
10/22/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:BNTC · CUSIP 08205P209 · CLASS common stock, par value $0.0001 per share · CIK 0001808898

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
0
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

01
Election of Class I Directors: Dr. Sharon Mates
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board recommends FOR the election of Dr. Sharon Mates.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
02
Election of Class I Directors: Kishen Mehta
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board recommends FOR the election of Kishen Mehta.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
03
Election of Class I Directors: Edward Smith
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board recommends FOR the election of Edward Smith.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of the appointment of the Company's independent registered public accounting firm for the fiscal year ending June 30, 2027.
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states there were no disagreements with Baker Tilly during the stated periods.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of the non-binding advisory vote on the compensation of the Company's named executive officers as disclosed in the Company's proxy statement.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board recommends FOR the non-binding advisory vote on executive compensation.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

ea45051490f8c2212150c524a966e308dd13d33b07a9510c514b0ff9f200b2df

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates